Liquid Biopsy and Non-small-cell Lung Cancer: Expecting More Fluid Management of Patients

Curr Pharm Biotechnol. 2023;24(3):351-354. doi: 10.2174/1389201023666220509145943.
No abstract available

MeSH terms

  • Biomarkers, Tumor
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / pathology
  • Humans
  • Liquid Biopsy
  • Lung Neoplasms* / diagnosis
  • Lung Neoplasms* / drug therapy
  • Mutation

Substances

  • Biomarkers, Tumor